Adults with type 1 diabetes had an increase in total daily insulin dose and bolus insulin dose shortly after stopping ...
We recently compiled a list of the 10 Quality Value Stocks Likely to Make a Comeback According to Analysts. Insulet ...
Beta Bionics today announced the launch of Bionic Insights™ , an innovative new feature within its Bionic Reports, designed to help healthcare providers (HCPs) make more informed, personalized ...
MiniMed Group Inc. is back as a locally based publicly traded company, having come full circle after 30 years. The Northridge ...
Beta Bionics, Inc. (Nasdaq: BBNX), a pioneering leader in the development of advanced diabetes management solutions, today announced that it plans to release its first quarter 2026 financial results ...
Biomea Fusion, Inc. ( BMEA) Discusses Menin Inhibition Mechanism and Therapeutic Potential in Diabetes March 30, 2026 3:00 PM EDT Michael J. Hitchcock - Interim CEO & Director Ramses Erdtmann - ...
India’s first clinical guidelines on micronutrients highlight the critical role of vitamins and minerals in patient recovery, from infections to chronic diseases and surgery ...
Background Cardiac sarcoidosis (CS) creates complex treatment challenges, especially for patients who fail to respond to ...
My goal in this letter is to begin to reconcile one of the most divisive and important debates in healthcare and nutrition today: the role of cholesterol in heart disease.
In this article, we will be taking a look at the 10 Quality Value Stocks Likely to Make a Comeback According to Analysts.
Illuminating your path’ was the theme chosen for this year’s Wellness Conference, hosted by Mnaamodzawin Health Services and ...
SUPER-1 evaluated GZR4 in insulin-naïve Chinese adults with T2DM, while SUPER-2 assessed those previously treated with basal insulin.
Some results have been hidden because they may be inaccessible to you
Show inaccessible results